Average Co-Inventor Count = 2.53
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Affymetrix, Inc. (9 from 560 patents)
2. Eos Biotechnology, Inc. (6 from 9 patents)
3. Protein Design Labs, Inc. (4 from 29 patents)
4. Pdl Biopharma, Inc. (2 from 20 patents)
5. Other (1 from 832,680 patents)
6. Leland Stanford Junior University (1 from 5,303 patents)
7. Princeton University (1 from 1,079 patents)
8. Cedars-sinai Medical Center (1 from 596 patents)
9. Abbott Biotherapeutics Corp. (1 from 13 patents)
24 patents:
1. 8313745 - Compositions against cancer antigen LIV-1 and uses thereof
2. 7736853 - Methods of diagnosis of androgen-dependent prostate cancer, prostate cancer undergoing androgen withdrawal, and androgen-independent prostate cancer
3. 7435589 - Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
4. 7252948 - Chip-based speciation and phenotypic characterization of microorganisms
5. 7189507 - Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
6. 6924094 - Chip-based species identification and phenotypic characterization of microorganisms
7. 6913882 - Methods of screening for B cell activity modulators
8. 6821724 - Methods of genetic analysis using nucleic acid arrays
9. 6780586 - Methods of diagnosing breast cancer
10. 6773878 - Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
11. 6762020 - Methods of diagnosing breast cancer
12. 6750013 - Methods for detection and diagnosing of breast cancer
13. 6733969 - Expression monitoring for gene function identification
14. 6682890 - Methods of diagnosing and determining prognosis of colorectal cancer
15. 6649342 - Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators